{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:18:50Z","timestamp":1790363930365,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970504"],"award-info":[{"award-number":["81970504"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-026-00978-w","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:44:11Z","timestamp":1782207851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular mechanisms of FSP1-regulated ferroptosis and therapeutic implications in various cancers"],"prefix":"10.1186","volume":"31","author":[{"given":"Congyue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemin","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"2","key":"978_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273\u201385.","journal-title":"Cell"},{"issue":"5","key":"978_CR2","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"34","key":"978_CR3","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci USA. 2016;113(34):E4966\u201375.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"978_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19(7):405\u201314.","journal-title":"Nat Rev Cancer"},{"issue":"7664","key":"978_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547(7664):453\u20137.","journal-title":"Nature"},{"issue":"6","key":"978_CR6","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/antiox12061218","volume":"12","author":"J Lee","year":"2023","unstructured":"Lee J, Roh JL. Unleashing ferroptosis in human cancers: targeting ferroptosis suppressor protein 1 for overcoming therapy resistance. Antioxidants (Basel). 2023;12(6):1218.","journal-title":"Antioxidants (Basel)"},{"key":"978_CR7","doi-asserted-by":"publisher","first-page":"104440","DOI":"10.1016\/j.critrevonc.2024.104440","volume":"202","author":"JL Roh","year":"2024","unstructured":"Roh JL. Targeting ferroptosis suppressor protein 1 in cancer therapy: implications and perspectives, with emphasis on head and neck cancer. Crit Rev Oncol Hematol. 2024;202:104440.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1-2","key":"978_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331.","journal-title":"Cell"},{"issue":"3","key":"978_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","volume":"172","author":"I Ingold","year":"2018","unstructured":"Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell. 2018;172(3):409.","journal-title":"Cell"},{"issue":"7784","key":"978_CR10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688\u201392.","journal-title":"Nature"},{"issue":"28","key":"978_CR11","doi-asserted-by":"publisher","first-page":"25617","DOI":"10.1074\/jbc.M202285200","volume":"277","author":"M Wu","year":"2002","unstructured":"Wu M, Xu LG, Li X, Zhai Z, Shu HB. AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein, induces caspase-independent apoptosis. J Biol Chem. 2002;277(28):25617\u201323.","journal-title":"J Biol Chem"},{"issue":"8","key":"978_CR12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599\u2013620.","journal-title":"Protein Cell"},{"issue":"7924","key":"978_CR13","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","volume":"608","author":"E Mishima","year":"2022","unstructured":"Mishima E, Ito J, Wu Z, Nakamura T, Wahida A, Doll S, et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature. 2022;608(7924):778\u201383.","journal-title":"Nature"},{"issue":"1","key":"978_CR14","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41467-023-36446-8","volume":"14","author":"DY Jin","year":"2023","unstructured":"Jin DY, Chen X, Liu Y, Williams CM, Pedersen LC, Stafford DW, et al. A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase. Nat Commun. 2023;14(1):828.","journal-title":"Nat Commun"},{"issue":"7\u20138","key":"978_CR15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s10495-024-01966-1","volume":"29","author":"R Gao","year":"2024","unstructured":"Gao R, Wang J, Huang J, Wang T, Guo L, Liu W, et al. FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications. Apoptosis. 2024;29(7\u20138):1019\u201337.","journal-title":"Apoptosis"},{"issue":"2","key":"978_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41418-022-01096-8","volume":"30","author":"F M\u00fcller","year":"2023","unstructured":"M\u00fcller F, Lim JKM, Bebber CM, Seidel E, Tishina S, Dahlhaus A, et al. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation. Cell Death Differ. 2023;30(2):442\u201356.","journal-title":"Cell Death Differ"},{"issue":"9","key":"978_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.molmed.2023.05.013","volume":"29","author":"W Li","year":"2023","unstructured":"Li W, Liang L, Liu S, Yi H, Zhou Y. FSP1: a key regulator of ferroptosis. Trends Mol Med. 2023;29(9):753\u201364.","journal-title":"Trends Mol Med"},{"issue":"2","key":"978_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3892\/or.2024.8764","volume":"52","author":"Q Dai","year":"2024","unstructured":"Dai Q, Wei X, Zhao J, Zhang D, Luo Y, Yang Y, et al. Inhibition of FSP1: a new strategy for the treatment of tumors (review). Oncol Rep. 2024;52(2):105.","journal-title":"Oncol Rep"},{"issue":"5","key":"978_CR19","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41419-022-04924-4","volume":"13","author":"M Yang","year":"2022","unstructured":"Yang M, Tsui MG, Tsang JKW, Goit RK, Yao KM, So KF, et al. Involvement of FSP1-CoQ10-NADH and GSH-GPx-4 pathways in retinal pigment epithelium ferroptosis. Cell Death Dis. 2022;13(5):468.","journal-title":"Cell Death Dis"},{"issue":"2","key":"978_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.chembiol.2015.11.016","volume":"23","author":"K Shimada","year":"2016","unstructured":"Shimada K, Hayano M, Pagano NC, Stockwell BR. Cell-line selectivity improves the predictive power of pharmacogenomic analyses and helps identify NADPH as biomarker for ferroptosis sensitivity. Cell Chem Biol. 2016;23(2):225\u201335.","journal-title":"Cell Chem Biol"},{"issue":"9","key":"978_CR21","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.chembiol.2023.04.007","volume":"30","author":"JM Hendricks","year":"2023","unstructured":"Hendricks JM, Doubravsky CE, Wehri E, Li Z, Roberts MA, Deol KK, et al. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis. Cell Chem Biol. 2023;30(9):1090.","journal-title":"Cell Chem Biol"},{"issue":"4","key":"978_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41419-023-05787-z","volume":"14","author":"TN Xavier da Silva","year":"2023","unstructured":"Xavier da Silva TN, Schulte C, Alves AN, Maric HM, Friedmann Angeli JP. Molecular characterization of AIFM2\/FSP1 inhibition by iFSP1-like molecules. Cell Death Dis. 2023;14(4):281.","journal-title":"Cell Death Dis"},{"issue":"12","key":"978_CR23","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula M, Weber RA, Zilka O, Alwaseem H, La K, Yen F, et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat Chem Biol. 2020;16(12):1351\u201360.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"978_CR24","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41467-019-09277-9","volume":"10","author":"Y Zou","year":"2019","unstructured":"Zou Y, Palte MJ, Deik AA, Li H, Eaton JK, Wang W, et al. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat Commun. 2019;10(1):1617.","journal-title":"Nat Commun"},{"issue":"12","key":"978_CR25","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1083\/jcb.201701136","volume":"216","author":"CW Brown","year":"2017","unstructured":"Brown CW, Amante JJ, Goel HL, Mercurio AM. The \u03b16\u03b24 integrin promotes resistance to ferroptosis. J Cell Biol. 2017;216(12):4287\u201397.","journal-title":"J Cell Biol"},{"issue":"5","key":"978_CR26","doi-asserted-by":"publisher","first-page":"e2006203","DOI":"10.1371\/journal.pbio.2006203","volume":"16","author":"H Feng","year":"2018","unstructured":"Feng H, Stockwell BR. Unsolved mysteries: how does lipid peroxidation cause ferroptosis? PLoS Biol. 2018;16(5):e2006203.","journal-title":"PLoS Biol"},{"issue":"13","key":"978_CR27","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186(13):2748.","journal-title":"Cell"},{"issue":"2","key":"978_CR28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbrc.2019.11.110","volume":"522","author":"E Dai","year":"2020","unstructured":"Dai E, Meng L, Kang R, Wang X, Tang D. ESCRT-III-dependent membrane repair blocks ferroptosis. Biochem Biophys Res Commun. 2020;522(2):415\u201321.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"978_CR29","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.bbrc.2020.01.066","volume":"523","author":"E Dai","year":"2020","unstructured":"Dai E, Zhang W, Cong D, Kang R, Wang J, Tang D. AIFM2 blocks ferroptosis independent of ubiquinol metabolism. Biochem Biophys Res Commun. 2020;523(4):966\u201371.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"978_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88.","journal-title":"Cell Death Dis"},{"issue":"10","key":"978_CR31","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.celrep.2019.07.107","volume":"28","author":"WH Yang","year":"2019","unstructured":"Yang WH, Ding CC, Sun T, Rupprecht G, Lin CC, Hsu D, et al. The hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma. Cell Rep. 2019;28(10):2501.","journal-title":"Cell Rep"},{"issue":"1","key":"978_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63(1):173\u201384.","journal-title":"Hepatology"},{"issue":"8","key":"978_CR33","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1038\/oncsis.2017.65","volume":"6","author":"Z Fan","year":"2017","unstructured":"Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M, Buchfelder M, et al. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis. 2017;6(8):e371.","journal-title":"Oncogenesis"},{"issue":"1","key":"978_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/iub.1895","volume":"71","author":"L Wang","year":"2019","unstructured":"Wang L, Zhang Z, Li M, Wang F, Jia Y, Zhang F, et al. P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation. IUBMB Life. 2019;71(1):45\u201356.","journal-title":"IUBMB Life"},{"issue":"8","key":"978_CR35","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41419-023-06070-x","volume":"14","author":"JW Kim","year":"2023","unstructured":"Kim JW, Kim MJ, Han TH, Lee JY, Kim S, Kim H, et al. FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner. Cell Death Dis. 2023;14(8):567.","journal-title":"Cell Death Dis"},{"issue":"10-12","key":"978_CR36","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/ars.2024.0608","volume":"41","author":"TA Muluh","year":"2024","unstructured":"Muluh TA, Fu Q, Ai X, Wang C, Chen W, Zheng X, et al. Targeting ferroptosis as an advance strategy in cancer therapy. Antioxid Redox Signal. 2024;41(10\u201312):616\u201336.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"978_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, et al. Role of mitochondria in ferroptosis. Mol Cell. 2019;73(2):354.","journal-title":"Mol Cell"},{"key":"978_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cca.2019.07.004","volume":"497","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Xu S, Xia H, Gao Z, Huang R, Tang E, et al. Long noncoding RNA FEZF1-AS1 in human cancers. Clin Chim Acta. 2019;497:20\u20136.","journal-title":"Clin Chim Acta"},{"issue":"10","key":"978_CR39","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.7150\/ijbs.72528","volume":"18","author":"N Li","year":"2022","unstructured":"Li N, Yi X, He Y, Huo B, Chen Y, Zhang Z, et al. Targeting ferroptosis as a novel approach to alleviate aortic dissection. Int J Biol Sci. 2022;18(10):4118\u201334.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"978_CR40","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41419-022-05515-z","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Cheng D, Wang Y, Xi S, Wang T, Sun W, et al. UHRF1-mediated ferroptosis promotes pulmonary fibrosis via epigenetic repression of GPX4 and FSP1 genes. Cell Death Dis. 2022;13(12):1070.","journal-title":"Cell Death Dis"},{"issue":"12","key":"978_CR41","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/cac2.12363","volume":"42","author":"X Zheng","year":"2022","unstructured":"Zheng X, Wang Q, Zhou Y, Zhang D, Geng Y, Hu W, et al. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Commun. 2022;42(12):1347\u201366.","journal-title":"Cancer Commun"},{"issue":"5","key":"978_CR42","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1165\/rcmb.2023-0467OC","volume":"72","author":"Y Yang","year":"2025","unstructured":"Yang Y, Shen W, Zhang Z, Dai Y, Zhang Z, Liu T, et al. FSP1 acts in parallel with GPX4 to inhibit ferroptosis in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2025;72(5):551\u201362.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"978_CR43","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1007\/s12094-022-03032-1","volume":"25","author":"C Bu","year":"2023","unstructured":"Bu C, Hu S, Yu J, Li N, Gu J, Sheng Z, et al. Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability. Clin Transl Oncol. 2023;25(5):1378\u201388.","journal-title":"Clin Transl Oncol"},{"key":"978_CR44","doi-asserted-by":"publisher","first-page":"8832043","DOI":"10.1155\/2020\/8832043","volume":"2020","author":"X Wei","year":"2020","unstructured":"Wei X, Yi X, Zhu XH, Jiang DS. Posttranslational modifications in ferroptosis. Oxid Med Cell Longev. 2020;2020:8832043.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"978_CR45","doi-asserted-by":"publisher","first-page":"101251","DOI":"10.1016\/j.gendis.2024.101251","volume":"12","author":"C Qiu","year":"2024","unstructured":"Qiu C, Cheng L, Di D, Xiang Z, Wang C, Li J, et al. TNF\u03b1-reliant FSP1 up-regulation promotes intervertebral disc degeneration via caspase 3-dependent apoptosis. Genes Dis. 2024;12(1):101251.","journal-title":"Genes Dis"},{"issue":"1","key":"978_CR46","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41467-021-21841-w","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Swanda RV, Nie L, Liu X, Wang C, Lee H, et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun. 2021;12(1):1589.","journal-title":"Nat Commun"},{"issue":"7755","key":"978_CR47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK, et al. CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569(7755):270\u20134.","journal-title":"Nature"},{"key":"978_CR48","doi-asserted-by":"publisher","first-page":"103864","DOI":"10.1016\/j.redox.2025.103864","volume":"87","author":"N Chaudhary","year":"2025","unstructured":"Chaudhary N, Mandal D, Choudhary BS, Patra S, Jain D, Poonia P, et al. Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation. Redox Biol. 2025;87:103864.","journal-title":"Redox Biol"},{"issue":"7860","key":"978_CR49","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593(7860):586\u201390.","journal-title":"Nature"},{"key":"978_CR50","doi-asserted-by":"publisher","first-page":"917634","DOI":"10.3389\/fonc.2022.917634","volume":"12","author":"K Wang","year":"2022","unstructured":"Wang K, Wang J, Zhang J, Zhang A, Liu Y, Zhou J, et al. Ferroptosis in glioma immune microenvironment: opportunity and challenge. Front Oncol. 2022;12:917634.","journal-title":"Front Oncol"},{"issue":"27","key":"978_CR51","doi-asserted-by":"publisher","first-page":"e2300994","DOI":"10.1002\/adhm.202300994","volume":"12","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Chen K, Lin WK, Liu J, Kang W, Zhang Y, et al. Photo-enhanced synergistic induction of ferroptosis for anti-cancer immunotherapy. Adv Healthc Mater. 2023;12(27):e2300994.","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"978_CR52","doi-asserted-by":"publisher","first-page":"e001369","DOI":"10.1136\/jitc-2020-001369","volume":"8","author":"I Efimova","year":"2020","unstructured":"Efimova I, Catanzaro E, Van der Meeren L, Turubanova VD, Hammad H, Mishchenko TA, et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer. 2020;8(2):e001369.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"978_CR53","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, et al. CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40(4):365.","journal-title":"Cancer Cell"},{"issue":"4","key":"978_CR54","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41418-024-01263-z","volume":"31","author":"H Miao","year":"2024","unstructured":"Miao H, Meng H, Zhang Y, Chen T, Zhang L, Cheng W. FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism. Cell Death Differ. 2024;31(4):497\u2013510.","journal-title":"Cell Death Differ"},{"issue":"8","key":"978_CR55","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1007\/s12094-023-03136-2","volume":"25","author":"J Zang","year":"2023","unstructured":"Zang J, Cui M, Xiao L, Zhang J, Jing R. Overexpression of ferroptosis-related genes FSP1 and CISD1 is related to prognosis and tumor immune infiltration in gastric cancer. Clin Transl Oncol. 2023;25(8):2532\u201344.","journal-title":"Clin Transl Oncol"},{"key":"978_CR56","doi-asserted-by":"publisher","first-page":"1074477","DOI":"10.3389\/fimmu.2022.1074477","volume":"13","author":"S Zhu","year":"2022","unstructured":"Zhu S, Wang Y, Tang J, Cao M. Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment. Front Immunol. 2022;13:1074477.","journal-title":"Front Immunol"},{"issue":"5","key":"978_CR57","doi-asserted-by":"publisher","first-page":"102431","DOI":"10.1016\/j.isci.2021.102431","volume":"24","author":"LM Song","year":"2021","unstructured":"Song LM, Xiao ZX, Zhang N, Yu XQ, Cui W, Xie JX, et al. Apoferritin improves motor deficits in MPTP-treated mice by regulating brain iron metabolism and ferroptosis. iScience. 2021;24(5):102431.","journal-title":"iScience"},{"key":"978_CR58","doi-asserted-by":"publisher","first-page":"6160701","DOI":"10.1155\/2022\/6160701","volume":"2022","author":"B Wang","year":"2022","unstructured":"Wang B, Zhang X, Zhong J, Wang S, Zhang C, Li M, et al. Dexpramipexole attenuates white matter injury to facilitate locomotion and motor coordination recovery via reducing ferroptosis after intracerebral hemorrhage. Oxid Med Cell Longev. 2022;2022:6160701.","journal-title":"Oxid Med Cell Longev"},{"key":"978_CR59","doi-asserted-by":"publisher","first-page":"116452","DOI":"10.1016\/j.taap.2023.116452","volume":"465","author":"X He","year":"2023","unstructured":"He X, Liang SM, Wang HQ, Tao L, Sun FF, Wang Y, et al. Mitoquinone protects against acetaminophen-induced liver injury in an FSP1-dependent and GPX4-independent manner. Toxicol Appl Pharmacol. 2023;465:116452.","journal-title":"Toxicol Appl Pharmacol"},{"key":"978_CR60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jare.2022.01.004","volume":"41","author":"S Wang","year":"2022","unstructured":"Wang S, Li W, Zhang P, Wang Z, Ma X, Liu C, et al. Mechanical overloading induces GPX4-regulated chondrocyte ferroptosis in osteoarthritis via Piezo1 channel facilitated calcium influx. J Adv Res. 2022;41:63\u201375.","journal-title":"J Adv Res"},{"issue":"5","key":"978_CR61","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/JLB.1A0422-211R","volume":"112","author":"J Guo","year":"2022","unstructured":"Guo J, Wang R, Min F. Ginsenoside Rg1 ameliorates sepsis-induced acute kidney injury by inhibiting ferroptosis in renal tubular epithelial cells. J Leukoc Biol. 2022;112(5):1065\u201377.","journal-title":"J Leukoc Biol"},{"key":"978_CR62","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fphar.2020.00239","volume":"11","author":"C Han","year":"2020","unstructured":"Han C, Liu Y, Dai R, Ismail N, Su W, Li B. Ferroptosis and its potential role in human diseases. Front Pharmacol. 2020;11:239.","journal-title":"Front Pharmacol"},{"issue":"24","key":"978_CR63","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.3390\/nu17243921","volume":"17","author":"J Pham","year":"2025","unstructured":"Pham J, Refesse M, Saeed A, Latunde-Dada GO. Haem oxygenase-1, ferroptosis and disorders\u2014A narrative review. Nutrients. 2025;17(24):3921.","journal-title":"Nutrients"},{"issue":"1","key":"978_CR64","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41420-025-02557-y","volume":"11","author":"K Ye","year":"2025","unstructured":"Ye K, Lan R, Chen Z, Lai K, Song Y, Li G, et al. Roles of ACSL4\/GPX4 and FSP1 in oxalate-induced acute kidney injury. Cell Death Discov. 2025;11(1):279.","journal-title":"Cell Death Discov"},{"key":"978_CR65","doi-asserted-by":"publisher","first-page":"117737","DOI":"10.1016\/j.ejmech.2025.117737","volume":"293","author":"W Liu","year":"2025","unstructured":"Liu W, Xie X, Zong H, Li Y, Ding Y, Liu Z, et al. Design, synthesis and biological evaluation of triazolothiadiazole derivatives as FSP1 inhibitors for sensitizing cancer cells to ferroptosis. Eur J Med Chem. 2025;293:117737.","journal-title":"Eur J Med Chem"},{"issue":"9","key":"978_CR66","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.chembiol.2023.08.015","volume":"30","author":"TN Xavier da Silva","year":"2023","unstructured":"Xavier da Silva TN, Friedmann Angeli JP. Sabotaging the breaks: FSEN1 expands the toolbox of FSP1 inhibitors. Cell Chem Biol. 2023;30(9):1006\u20138.","journal-title":"Cell Chem Biol"},{"issue":"7823","key":"978_CR67","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"Ubellacker JM, Tasdogan A, Ramesh V, Shen B, Mitchell EC, Martin-Sandoval MS, et al. Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 2020;585(7823):113\u20138.","journal-title":"Nature"},{"issue":"11","key":"978_CR68","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.21873\/anticanres.17316","volume":"44","author":"C Yasui","year":"2024","unstructured":"Yasui C, Kono Y, Ishiguro R, Yagyu T, Kyoichi K, Yamamoto M, et al. New treatment modalities for colorectal cancer through simultaneous suppression of FSP1 and GPX4. Anticancer Res. 2024;44(11):4905\u201314.","journal-title":"Anticancer Res"},{"issue":"2","key":"978_CR69","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1021\/acsnano.1c08664","volume":"16","author":"K Li","year":"2022","unstructured":"Li K, Lin C, Li M, Xu K, He Y, Mao Y, et al. Multienzyme-like reactivity cooperatively impairs glutathione peroxidase 4 and ferroptosis suppressor protein 1 pathways in triple-negative breast cancer for sensitized ferroptosis therapy. ACS Nano. 2022;16(2):2381\u201398.","journal-title":"ACS Nano"},{"issue":"13","key":"978_CR70","doi-asserted-by":"publisher","first-page":"e2102799","DOI":"10.1002\/adhm.202102799","volume":"11","author":"J Yang","year":"2022","unstructured":"Yang J, Jia Z, Zhang J, Pan X, Wei Y, Ma S, et al. Metabolic intervention nanoparticles for triple-negative breast cancer therapy via overcoming FSP1-mediated ferroptosis resistance. Adv Healthc Mater. 2022;11(13):e2102799.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"978_CR71","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula P, Lei G, Zhang Y, Yan Y, Mao C, Kondiparthi L, et al. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun. 2022;13(1):2206.","journal-title":"Nat Commun"},{"issue":"1","key":"978_CR72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41556-021-00818-3","volume":"24","author":"HL Zhang","year":"2022","unstructured":"Zhang HL, Hu BX, Li ZL, Du T, Shan JL, Ye ZP, et al. PKC\u03b2II phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis. Nat Cell Biol. 2022;24(1):88\u201398.","journal-title":"Nat Cell Biol"},{"key":"978_CR73","doi-asserted-by":"publisher","first-page":"113636","DOI":"10.1016\/j.biopha.2022.113636","volume":"154","author":"M Wang","year":"2022","unstructured":"Wang M, Cheng H, Wu H, Liu C, Li S, Li B, et al. Gambogenic acid antagonizes the expression and effects of long non-coding RNA NEAT1 and triggers autophagy and ferroptosis in melanoma. Biomed Pharmacother. 2022;154:113636.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"978_CR74","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180\u201391.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"978_CR75","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41420-024-01854-2","volume":"10","author":"E Panczyszyn","year":"2024","unstructured":"Panczyszyn E, Saverio V, Monzani R, Gagliardi M, Petrovic J, Stojkovska J, et al. FSP1 is a predictive biomarker of osteosarcoma cells\u2019 susceptibility to ferroptotic cell death and a potential therapeutic target. Cell Death Discov. 2024;10(1):87.","journal-title":"Cell Death Discov"},{"issue":"4","key":"978_CR76","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/CAD.0000000000001676","volume":"36","author":"H Xing","year":"2025","unstructured":"Xing H, Bi HN, Yin Q, Zhang J, Zhang X, Li YJ, et al. FSP1 expression as a predictor of platinum resistance and recurrence in epithelial ovarian cancer. Anticancer Drugs. 2025;36(4):338\u201346.","journal-title":"Anticancer Drugs"},{"issue":"22","key":"978_CR77","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2217\/fon-2020-0332","volume":"16","author":"K Kunimasa","year":"2020","unstructured":"Kunimasa K, Matsumoto S, Nishino K, Nakamura H, Kuhara H, Tamiya M, et al. Improvement strategies for successful next-generation sequencing analysis of lung cancer. Future Oncol. 2020;16(22):1597\u2013606.","journal-title":"Future Oncol"},{"issue":"1","key":"978_CR78","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11307-021-01631-y","volume":"24","author":"Z Han","year":"2022","unstructured":"Han Z, Ke M, Liu X, Wang J, Guan Z, Qiao L, et al. Molecular imaging, how close to clinical precision medicine in lung, brain, prostate and breast cancers. Mol Imaging Biol. 2022;24(1):8\u201322.","journal-title":"Mol Imaging Biol"},{"key":"978_CR79","doi-asserted-by":"publisher","first-page":"117237","DOI":"10.1016\/j.taap.2025.117237","volume":"495","author":"R Zou","year":"2025","unstructured":"Zou R, Liu Z, Wang P, Liu Y. Ginkgolide B binds to GPX4 and FSP1 to alleviate cerebral ischemia\/reperfusion injury in rats. Toxicol Appl Pharmacol. 2025;495:117237.","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-026-00978-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00978-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00978-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:03:02Z","timestamp":1789045382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-026-00978-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1186\/s11658-026-00978-w","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"140"}}